Natural Products for the Treatment of Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction that significantly impacts quality of life. Studies indicate that more than one-third of patients with IBS use nonphar-macologic therapies, which include natural products and mind-body therapies, with higher prevalence identified among women, younger individuals, and those with higher education levels. This article examines the efficacy and safety of various natural products for the treatment of IBS, including fiber supplements, probiotics, herbal remedies (including Aloe vera and peppermint oil), and dietary supplements. Although some therapies show promise in symptom management, the evidence remains mixed for many of these interventions. Further high-quality research is needed to establish the role of many of these therapies in IBS treatment.

Authors

Publication Details

Journal
Europe PMC (PubMed Central)
Published
2025-09-01
Primary Topic
Gastrointestinal motility and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Natural Products for the Treatment of Irritable Bowel Syndrome

Sophie L. Brigstocke, Darren M. Brenner
Europe PMC (PubMed Central)
Gastrointestinal motility and disorders
article

Natural Products for the Treatment of Irritable Bowel Syndrome

Sophie L. Brigstocke, Darren M. Brenner
article en

Abstract

Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction that significantly impacts quality of life. Studies indicate that more than one-third of patients with IBS use nonphar-macologic therapies, which include natural products and mind-body therapies, with higher prevalence identified among women, younger individuals, and those with higher education levels. This article examines the efficacy and safety of various natural products for the treatment of IBS, including fiber supplements, probiotics, herbal remedies (including Aloe vera and peppermint oil), and dietary supplements. Although some therapies show promise in symptom management, the evidence remains mixed for many of these interventions. Further high-quality research is needed to establish the role of many of these therapies in IBS treatment.

Europe PMC (PubMed Central)
Openalex Percentile: Top 23%
Gastrointestinal motility and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.